Phase I oncology — 3+3 dose escalation and MTD rules
The 3+3 dose-escalation decision rules for a first-in-human phase I oncology trial — the CTCAE v5.0 dose-limiting toxicity definition, the 0/3, 1/3 and ≥2/3 cohort decisions, expansion to six patients, de-escalation, the MTD definition (≤1 DLT in 6 evaluable patients) and the RP2D expansion cohort — the escalation schema every phase I protocol and DSMB charter must state.
Rendering…
Make it your own.
digraph three_plus_three {
rankdir=TB;
graph [fontname="Helvetica", fontsize=11, nodesep=0.4, ranksep=0.45, bgcolor="transparent",
label="Phase I oncology — 3+3 dose-escalation decision rules\lDLT window: cycle 1 (28 days). A patient who receives < 75% of the planned cycle-1 dose for a reason other than toxicity is not DLT-evaluable and is replaced.\lMTD is the highest dose level at which ≤ 1 of 6 DLT-evaluable patients experiences a DLT. Escalation is modified Fibonacci: +100%, +67%, +50%, +40%, +33%.\l",
labelloc="t", labeljust="l"];
node [fontname="Helvetica", fontsize=9, shape=box, style="rounded,filled", fillcolor="#f8fafc", color="#64748b", margin="0.16,0.10"];
edge [fontname="Helvetica", fontsize=8, color="#475569"];
subgraph cluster_dlt {
label="Dose-limiting toxicity — CTCAE v5.0, cycle 1 only"; style="rounded,filled"; fillcolor="#fff1f2"; color="#fda4af"; fontsize=10; fontcolor="#be123c";
dlt [label="Any of:\l • Grade ≥ 3 non-haematological toxicity, except untreated nausea,\l vomiting, diarrhoea or alopecia\l • Grade 4 neutropenia lasting > 7 days\l • Grade ≥ 3 febrile neutropenia\l • Grade 4 thrombocytopenia, or grade 3 with clinically\l significant bleeding or a platelet transfusion\l • Grade ≥ 3 AST/ALT rise lasting > 7 days\l • Any toxicity delaying the start of cycle 2 by > 14 days\l", fillcolor="#ffe4e6"];
}
enrol [label="Enrol a cohort of 3 DLT-evaluable patients\lat dose level i (level 1 = one tenth of the LD10 in mice)\l", fillcolor="#dbeafe", color="#2563eb"];
obs [label="Observe all 3 through the full 28-day DLT window\lbefore any further patient is dosed", fillcolor="#eff6ff"];
d [label="How many of the 3 had a DLT?", shape=diamond, style="filled", fillcolor="#fef3c7", color="#d97706", margin="0.10,0.05"];
esc [label="0 of 3 — escalate\lopen dose level i+1 with a new cohort of 3", fillcolor="#dcfce7", color="#16a34a"];
exp [label="1 of 3 — expand this level\lenrol 3 more at dose level i (6 in total)", fillcolor="#fef9c7"];
stop3 [label="≥ 2 of 3 — dose exceeded\lstop escalation; this level is above the MTD", fillcolor="#fee2e2", color="#dc2626"];
d6 [label="How many of the 6 had a DLT?", shape=diamond, style="filled", fillcolor="#fef3c7", color="#d97706", margin="0.10,0.05"];
esc6 [label="1 of 6 — escalate\lopen dose level i+1 with a new cohort of 3", fillcolor="#dcfce7", color="#16a34a"];
stop6 [label="≥ 2 of 6 — dose exceeded\lstop escalation; this level is above the MTD", fillcolor="#fee2e2", color="#dc2626"];
back [label="Was the previous dose level already treated with 6 patients?", shape=diamond, style="filled", fillcolor="#fef3c7", color="#d97706", margin="0.10,0.05"];
fill [label="No — enrol 3 more at dose level i−1\lso that 6 patients are evaluable there", fillcolor="#eff6ff"];
mtd [label="MTD DECLARED = dose level i−1\lthe highest level with ≤ 1 DLT in 6 evaluable patients\lRP2D is usually the MTD, adjusted for cumulative toxicity,\lPK exposure and target engagement across all cycles\l", fillcolor="#ede9fe", color="#6d28d9"];
deesc [label="Dose level 1 exceeded\lde-escalate to level −1 (typically 50% of level 1);\lif level −1 is also exceeded, close the escalation\l", fillcolor="#fee2e2", color="#dc2626"];
expand [label="Expansion cohort at the RP2D\ltypically 6–12 further patients to confirm tolerability\land collect a preliminary efficacy signal\l", fillcolor="#f3e8ff"];
enrol -> obs;
obs -> d;
d -> esc [label=" 0/3"];
d -> exp [label=" 1/3"];
d -> stop3 [label=" ≥ 2/3"];
esc -> enrol [label=" next dose level, new cohort of 3", constraint=false];
exp -> d6;
d6 -> esc6 [label=" 1/6"];
d6 -> stop6 [label=" ≥ 2/6"];
esc6 -> enrol [label=" next dose level, new cohort of 3", constraint=false];
stop3 -> back;
stop6 -> back;
back -> fill [label=" no"];
back -> mtd [label=" yes"];
back -> deesc [label=" the exceeded level was level 1"];
fill -> mtd [label=" ≤ 1 DLT in 6"];
fill -> back [label=" ≥ 2 DLT in 6 — step down again", style=dashed];
mtd -> expand;
dlt -> d [style=dashed, color="#be123c", label=" scores each patient"];
}